Next 10 |
home / stock / fmcqf / fmcqf news
2024-03-21 10:22:39 ET More on Becton, Dickinson Becton, Dickinson And Company: Growth Starts To Normalize (Rating Upgrade) Becton, Dickinson and Company 2024 Q1 - Results - Earnings Call Presentation Becton, Dickinson and Company (BDX) Q1 2024 Earnings Call Transcri...
2024-03-05 07:30:03 ET More on Baxter, DaVita, etc. Baxter International Inc. Is A Buy (Technical Analysis) Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts Broyhill - Fresenius Medical Care: Correctly Focused On Increas...
2024-02-23 10:20:00 ET Summary We established a position in Fresenius Medical Care, a German healthcare company specializing in kidney dialysis and related products, at "Peak Obesity" in October of last year. At current prices, shares appear to discount only the worst possible sce...
2024-02-20 12:03:05 ET Fresenius Medical Care AG (FMS) Q4 2023 Earnings Conference Call February 20, 2024, 08:00 AM ET Company Participants Dominik Heger - Head of Investor Relations Helen Giza - Chief Executive Officer and Chair Martin Fischer - Chief Financial ...
2024-02-20 07:57:29 ET More on Fresenius Medical Care Fresenius Medical Care: What Can We Expect For 2024E Seeking Alpha’s Quant Rating on Fresenius Medical Care Historical earnings data for Fresenius Medical Care Dividend scorecard for Fresenius Medic...
2024-01-10 23:55:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
2023-12-28 08:16:55 ET Summary Fresenius Medical Care has seen a recovery in its share price after a dip in October 2023, presenting an attractive upside potential. The company's 3Q23 results showed continued organic growth, successful execution of its turnaround plan, and raised ...
2023-12-14 12:30:25 ET The Biden administration on Thursday named 48 Medicare Part B drugs that could be subject to inflation penalties for Q1 2024, including products from the likes of AbbVie ( NYSE: ABBV ), Amgen ( NASDAQ: AMGN ), and Pfizer ( NYSE: PFE ). Drug...
2023-11-02 16:51:03 ET Fresenius Medical Care AG & Co. KGaA (FMS) Q3 2023 Earnings Conference Call November 02, 2023, 10:30 ET Company Participants Dominik Heger - EVP & Head, IR, Strategic Development & Communications Helen Giza - CEO Martin Fischer ...
2023-11-02 03:48:57 ET More on Fresenius Medical Care Fresenius Medical Care: Don't Let The Ozempic Kidney Failure Scare You Off Fresenius sees GLP-1 drugs having neutral impact on its business: report Dialysis stocks decline again as Novo Nordisk hits 52-week high ...